Loading news...
Reckitt Benckiser Group plc (OTCMKTS:RBGPF - Get Free Report)'s share price fell 0.3% during trading on Wednesday. The company traded as low as $81.3550 and last traded at $81.3550. 657 shares changed hands during trading, a decline of 40% from the average session volume of 1,089 shares. The stock had previously closed at $81.57.
Reckitt Benckiser Group PLC (LSE:RKT, XETRA:3RB) has received sharply contrasting verdicts from analysts, after RBC Capital Markets downgraded the shares while Deutsche Bank renewed its 'buy' rating, underlining the tension between near-term uncertainty and longer-term strategic appeal. RBC cut its rating to 'sector perform' from 'outperform', trimming its price target to £62, as it incorporated the disposal of the Essential Home business, the forthcoming £1.6 billion special dividend and the related share consolidation into its forecasts.
Reckitt Benckiser Group PLC (LSE:RKT, XETRA:3RB) has unveiled plans to hand back about £1.6 billion to shareholders through a one-off special dividend, following the sale of its Essential Home business. The consumer goods group said it intends to pay a special dividend of 235 pence a share after completing the disposal of the division to Advent International, a deal announced at the end of December.
Influencers and AI-generated avatars selling everything from Durex condoms to Harpic toilet cleaner on livestreaming apps in China are propelling emerging-market led growth for consumer goods company Reckitt.
Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript
Reckitt Benckiser Group PLC's (LSE:RKT, ETR:3RB) turnaround may finally be gaining traction. RBC Capital Markets has raised its price target from £60 to £64 and reiterated an outperform rating, arguing that the consumer goods group is building a record of reliable mid-single-digit growth and improved execution under its “Fuel for Growth” plan.
Sales grew 7% on a like-for-like basis, lifted by consumer spending on self-care, germ-protection and sexual-health products.
Reckitt Benckiser Group Plc. ADR (OTCPK:RBGLY) Q3 2025 Sales Call October 22, 2025 3:30 AM EDT Company Participants Nicholas Ashworth - Head of Investor Relations Kris Licht - CEO & Executive Director Shannon Eisenhardt - CFO & Executive Director Conference Call Participants Guillaume Gerard Delmas - UBS Investment Bank, Research Division Warren Ackerman - Barclays Bank PLC, Research Division David Hayes - Jefferies LLC, Research Division Celine Pannuti - JPMorgan Chase & Co, Research Division Jeremy Fialko - HSBC Global Investment Research Edward Lewis - Rothschild & Co Redburn, Research Division Rashad Kawan - Morgan Stanley, Research Division Tom Sykes - Deutsche Bank AG, Research Division Presentation Nicholas Ashworth Head of Investor Relations Good morning, everybody, and welcome to Reckitt's Q3 trading update.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) reported a stronger-than-expected sales performance in the third quarter, helped by a return to growth in developed markets. The FTSE 100-listed consumer health and hygiene company reported net revenues of £3.6 billion, a 7.0% rise on a like-for-like basis, supported by strong growth in its core products.
There's nothing like a sniffle season to remind investors of Reckitt Benckiser Group PLC's (LSE:RKT, ETR:3RB) place in the bathroom cabinet. The maker of Nurofen, Dettol and Durex is due to update the market on 22 October, and UBS reckons the numbers will show a business picking up pace after a sluggish start to the year.
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Reckitt Benckiser Group PLC (“Reckitt” or “the Company”) (OTCMKTS: RBGLY) and certain of its officers.
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Reckitt (RBGLY) To Contact Him Directly To Discuss Their Options
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.
NEW ORLEANS, La., July 31, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY), if they purchased the Company's American Depositary Shares (“ADSs”) between January 13, 2021 and July 28, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Reckitt Benckiser Group plc (“Reckitt” or the “Company”) (OTC:RBGLY) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Reckitt securities between January 13, 2021, and July 28, 2024, both dates inclusive (the “Class Period”). Investors have until August 4, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
LOS ANGELES, July 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Reckitt Benckiser Group PLC ("Reckitt Benckiser" or the "Company") (OTC: RBGLY) investors of a class action representing investors that bought securities between January 13, 2021 and July 28, 2024, inclusive (the "Class Period"). Reckitt Benckiser investors have until August 4, 2025 to file a lead plaintiff motion.
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Southern District of New York against Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on behalf of all persons other than Defendants who purchased or otherwise acquired Reckitt American Depositary Shares (“ADSs”) between January 13, 2021, and July 28, 2024, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Scott+Scott is captioned: Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, et al., Case No. 1:25-cv-4708.
NEW YORK, July 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc ("Reckitt" or the "Company") (OTCMKTS: RBGLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.